3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
3
Unknown
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
11
Breast
3
Thoracic
2
Plasma cell
2
Lymphoid
2
Gynecologic
2
Genitourinary
2
Other neoplasm
1
Other hematologic neoplasm
1
Head & Neck
1
CNS
1
Conditions
Multiple Myeloma
2
Recurrence
1
Infections
1
Interventions
Dexamethasone
69
Cyclophosphamide
43
Bortezomib
40
Lenalidomide
24
Melphalan
22
Thalidomide
19
pomalidomide
17
fludarabine
13
daratumumab
13
carfilzomib
10
Doxorubicin
8
Filgrastim
7
Busulfan
6
isatuximab
5
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Calcium Dobesilate
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
liposomal doxorubicin
3
ixazomib
3
dexamethasone acetate
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Observation
×
Plasma cell
×
Clear all
NCT02572492
2018-08-17
CARFI
Aalborg University Hospital
Phase 2
Unknown
200 enrolled
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled